| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $251.7M | -39.9% |
| Cost of Revenue | $67.9M | -48.3% |
| Gross Profit | $183.8M | -36.0% |
| R&D Expense | $1.7M | +6.3% |
| SG&A Expense | $39.9M | -18.9% |
| Operating Income | $5.5M | +108.3% |
| Interest Expense | $5.0M | -27.7% |
| Pre-tax Income | -$2.7M | +96.2% |
| Income Tax | $125K |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $39.0M | +93.3% |
| Accounts Receivable | $1.1M | -21.5% |
| Inventory | $9.4M | -42.3% |
| Current Assets | $63.8M | -18.9% |
| Total Assets | $147.0M | -15.8% |
| Current Liabilities | $86.6M | -32.2% |
| Long-term Debt | $25.0M | +15.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $21.8M | +748.9% |
| Capital Expenditures | $4.4M | -3.1% |
| Investing Cash Flow | -$4.4M | -515.8% |
| Financing Cash Flow | $1.0M | +106.5% |
| Free Cash Flow | $17.4M | +976.3% |
| -47.7% |
| Net Income | -$2.9M | +96.0% |
| EPS (Basic) | -$0.41 | +96.1% |
| EPS (Diluted) | -$0.41 | +96.1% |
| Total Liabilities |
| $115.7M |
| -21.0% |
| Stockholders' Equity | $31.3M | +11.2% |